alpha-aminopyridine has been researched along with Wallerian Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishibashi, K; Ishii, K; Kameyama, M; Tago, T; Toyohara, J | 1 |
| Chiu, SY; Wilson, GF | 1 |
2 other study(ies) available for alpha-aminopyridine and Wallerian Degeneration
| Article | Year |
|---|---|
Potential Use of 18F-THK5351 PET to Identify Wallerian Degeneration of the Pyramidal Tract Caused by Cerebral Infarction.
Topics: Adult; Aminopyridines; Cerebral Infarction; Humans; Male; Positron-Emission Tomography; Quinolines; Wallerian Degeneration | 2017 |
The role of potassium channels in Schwann cell proliferation in Wallerian degeneration of explant rabbit sciatic nerves.
Topics: 4-Aminopyridine; Aminopyridines; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Female; Gramicidin; Male; Membrane Potentials; Microbial Collagenase; Mitosis; Nerve Degeneration; Potassium Channels; Quinine; Rabbits; Schwann Cells; Sciatic Nerve; Tetraethylammonium Compounds; Veratridine; Wallerian Degeneration | 1989 |